Lymphatic Radiobiology
淋巴放射生物学
基本信息
- 批准号:8326221
- 负责人:
- 金额:$ 23.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-12 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirus VectorAdenovirusesAdvocateAffectAftercareAnimal ModelAnimalsApoptoticAreaAwardAxillaAxillary Lymph Node DissectionBiochemistryBiological AssayBloodCaliberCancer PatientCell DeathCell ProliferationCell divisionCellsCessation of lifeCommitComplementComplicationDataDermalDevelopmentDoseEarEndothelial CellsEngineeringEquipmentExposure toFailureFibroblast Growth Factor 2FutureGeneral HospitalsGoalsGrowthGrowth FactorGrowth Factor ReceptorsHumanImageImaging technologyImmunohistochemistryIn VitroIncidenceIncubatedInfectionIonizing radiationK-Series Research Career ProgramsKineticsLaboratoriesLeadLightLymphangiogenesisLymphangiographyLymphaticLymphatic Endothelial CellsLymphatic vesselLymphedemaMalignant NeoplasmsMeasuresMediatingMentorsMentorshipMethodsMitosisMitoticMolecularMolecular BiologyMolecular TargetMonitorMusNatureNecrosisNeuropilin-1Neuropilin-2Operative Surgical ProceduresPainPathway interactionsPatientsPhasePre-Clinical ModelPreventionPrior TherapyProliferatingRadiationRadiation ToleranceRadiation induced damageRadiation therapyRadiation-Sensitizing AgentsRadiobiologyRelative (related person)ResearchResearch PersonnelResearch TrainingRiskSeedsSignal PathwaySignal TransductionSignaling MoleculeStaining methodStainsSwellingTechniquesTestingTherapeuticTissuesTrainingUnited StatesVascular Endothelial CellVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3VenousWomanWorkcancer cellcareerdesignexperiencefibroblast growth factor receptor 3genetic manipulationin vitro Modelin vivoinhibitor/antagonistintravital microscopyirradiationknowledge baselymph flowmalignant breast neoplasmnovelpreventradiation effectrepairedresearch studyresponsesenescenceskillssmall hairpin RNAsuccesstime usetooltreatment planning
项目摘要
Axillary radiation with surgery in breast cancer patients often leads to lymphedema, which affects nearly
400,000 women in the United States. Lymphedema is disfiguring, painful and forms a nidus for infection. As
current treatments provide little relief for many patients, it is critical to develop methods to prevent and
reverse the formation of lymphedema. The use of lymphangiogenic growth factors to spur lymphatic growth
and reverse lymphedema has been advocated. However, in cancer patients this strategy may facilitate the
further spread of cancer cells. To avoid this complication, we focus on lymphedema prevention in this
Pathway to Independence Award.
While information on the radiosensitivity of many tissues Is available, the effects of radiation on lymphatic
vessels have been largely unreported. In this proposal we will study the radiosensitivity of lymphatic
endothelial cells and their cellular and molecular response to radiation. We will then alter lymphatic
endothelial cell radiosensitivity through exposure to growth factors or genetic manipulation of growth factor
signaling. We will complement these studies by measuring the radiosensitivity of normal and proliferating
lymphatic vessels In vivo. Finally, we will prevent radiation-induced damage of lymphangiogenic vessels by
administering inhibitors of lymphatic growth factor receptors. The ultimate goal of this project is to identify
strategies to protect lymphatic vessels from radiation-induced damage in order to prevent lymphedema in
patients.
I will complete this worl< in the E.L. Steele Laboratories at IVIassachusetts General Hospital, which has the
approriate animal faciiities and intravital Imaging equipment necessary for the proposed experlmeints. My
mentors, Drs. Brian Seed and Kathryn Held, will continue to collaborate with me on this project and are
committed to the development of my career and will help my transition into a successful independent
academic researcher.
乳腺癌患者进行手术的腋窝辐射通常会导致淋巴水肿,这几乎影响
美国有40万名妇女。淋巴水肿是毁容的,疼痛的,并且形成了感染的Nidus。作为
目前的治疗几乎没有减轻许多患者,开发预防和预防方法至关重要
逆转淋巴水肿的形成。淋巴管生长因子的使用来刺激淋巴生长
并且已经提倡反向淋巴水肿。但是,在癌症患者中,这种策略可能有助于
癌细胞进一步扩散。为了避免这种并发症,我们专注于预防淋巴水肿
独立奖。
虽然提供了许多组织的放射敏感性的信息,但辐射对淋巴的影响
船只在很大程度上没有报道。在此提案中,我们将研究淋巴的放射敏性
内皮细胞及其对辐射的细胞和分子反应。然后,我们将改变淋巴
内皮细胞放射敏感性通过暴露于生长因子或生长因子的遗传操纵
信号。我们将通过测量正常和增殖的放射敏感性来补充这些研究
体内淋巴管。最后,我们将防止通过
施用淋巴生长因子受体的抑制剂。该项目的最终目标是确定
保护淋巴管免受辐射引起的损伤的策略,以防止淋巴水肿
患者。
我将在E.L.中完成此werl。 Iviassachusetts综合医院的Steele Laboratories
拟议的实验所需的优义动物智能和内加成像设备。我的
导师,博士。 Brian Seed和Kathryn Held将继续与我合作,
致力于发展我的职业生涯,并将帮助我过渡到成功的独立
学术研究员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY P PADERA其他文献
TIMOTHY P PADERA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY P PADERA', 18)}}的其他基金
Targeting lymph node metastases to block cancer progression
针对淋巴结转移阻止癌症进展
- 批准号:
10743193 - 财政年份:2023
- 资助金额:
$ 23.75万 - 项目类别:
Reversing aging-induced lymphatic dysfunction to improve immune function
逆转衰老引起的淋巴功能障碍,改善免疫功能
- 批准号:
10371505 - 财政年份:2022
- 资助金额:
$ 23.75万 - 项目类别:
Reversing aging-induced lymphatic dysfunction to improve immune function
逆转衰老引起的淋巴功能障碍,改善免疫功能
- 批准号:
10544735 - 财政年份:2022
- 资助金额:
$ 23.75万 - 项目类别:
Targeting lymph node metastases to prevent cancer progression
针对淋巴结转移预防癌症进展
- 批准号:
9286149 - 财政年份:2017
- 资助金额:
$ 23.75万 - 项目类别:
Targeting lymph node metastases to prevent cancer progression
针对淋巴结转移以预防癌症进展
- 批准号:
10542290 - 财政年份:2017
- 资助金额:
$ 23.75万 - 项目类别:
Characterization of lymphatic contraction during infection
感染期间淋巴收缩的特征
- 批准号:
8422972 - 财政年份:2012
- 资助金额:
$ 23.75万 - 项目类别:
Characterization of lymphatic contraction during infection
感染期间淋巴收缩的特征
- 批准号:
8225628 - 财政年份:2012
- 资助金额:
$ 23.75万 - 项目类别:
Characterizing lymphatic micrometastases: prognostic and therapeutic implications
淋巴微转移的特征:预后和治疗意义
- 批准号:
8146385 - 财政年份:2011
- 资助金额:
$ 23.75万 - 项目类别:
相似国自然基金
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
- 批准号:82302607
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型腺病毒载体Ad49L介导的高水平干扰素α抑制疫苗体液免疫的机制
- 批准号:82302001
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
新型腺病毒载体疫苗长效免疫机制
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
新型腺病毒载体疫苗长效免疫机制
- 批准号:82271868
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
基于肠道腺病毒载体平台COVID-19粘膜疫苗的设计与筛选
- 批准号:82161138001
- 批准年份:2021
- 资助金额:150 万元
- 项目类别:国际(地区)合作与交流项目
相似海外基金
Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer
推进溶瘤腺病毒治疗胰腺癌的系统递送
- 批准号:
10734709 - 财政年份:2023
- 资助金额:
$ 23.75万 - 项目类别:
Pulmonary endothelium targeted adenoviral gene therapy for the correction of mucopolysaccharidosis type I
肺内皮靶向腺病毒基因治疗纠正 I 型粘多糖贮积症
- 批准号:
10678053 - 财政年份:2023
- 资助金额:
$ 23.75万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 23.75万 - 项目类别:
Validation and Improvement of ISPRI-HCP: An Innovative Platform for Immunogenicity Risk Assessment of Process-related Protein Impurities
ISPRI-HCP 的验证和改进:工艺相关蛋白质杂质免疫原性风险评估的创新平台
- 批准号:
10603538 - 财政年份:2023
- 资助金额:
$ 23.75万 - 项目类别: